The standard diagnostic test for osteoporosis is dual-energy X-ray absorptiometry (DXA)-based measurement of BMD of the lumbar spine and total hip 1 . This test has been available in clinical practice for >30 years. The DXA technique uses only a very small radiation dose and is therefore widely used in research as well as in clinical practice. Osteoporosis is defined as a BMD T-score of ≤−2.5 using DXA, where a BMD T-score is the number of standard deviations from the mean value for a healthy 30-year old 1 . The T-score can be combined with clinical risk factors such as prior fracture and body weight to calculate the 10-year risk of osteoporotic fracture and to guide treatment decisions. However, the predictive power of the T-score alone is limited, as many patients who fracture have a T-score of >−2.5. The BMD measured by DXA does not provide separate information about cortical and trabecular bone, or bone microarchitecture. The separate quantification of trabecular and cortical bone allows a better understanding of how bone is lost with ageing and which type of bone loss (cortical or trabecular) is most strongly associated with fracture risk.
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Quantitative CT (QCT) images the bone in 3D and can provide separate information about cortical and trabecular bone. However, at these central sites the radiation dose is high when imaging the spine and proximal femur and the QCT images are relatively low
HRpQCT-based measurements of the radius and tibia and incident fragility fracture during a 5-year follow-up period in 149 women aged >60 years. Women who fractured had a lower baseline BMD and different geometric and microstructural properties at the radius (lower trabecular number and greater spacing) and tibia (lower trabecular area, cortical area, cortical thickness and failure load) compared with women who did not fracture. For every standard deviation decrease in total BMD or trabecular BMD at the radius and tibia, the risk of non-vertebral fracture increased 1.7-2.1-fold. This finding was similar to the effect size obtained from baseline DXA-based femoral neck BMD. Surprisingly, there was no association between fracture risk and baseline DXA-based BMD of the lumbar spine and total hip, or bone loss assessed by DXA or HRpQCT.
This study is interesting as it adds to the growing evidence in support of the value of HRpQCT for fracture prediction and is the third study to prospectively evaluate this issue 4 (TABLE 1). The common findings among these studies were the strong associations between total BMD and trabecular BMD at the radius and vertebral and non-vertebral fractures. The only microstructural variable consistently associated with fracture across all studies was trabecular number. The fracture prediction in some of the studies 5, 6 was independent of DXA-based assessment of BMD of the hip, 10-year fracture risk, falls, the use of drugs for osteoporosis, current smoking status, prior fracture and age. Fracture prediction was not independent of ultradistal radius BMD in one study, suggesting that at a practical level an ultradistal BMD measured by DXA could be just as helpful as measurements by HRpQCT 5 .
The most important finding from these three studies was that HRpQCT-based measurements strongly predicted vertebral and non-vertebral fractures. The association with major fractures (distal radius, proximal humerus, proximal femur and vertebrae) was even stronger than for all fractures. Equally interesting was the finding that trabecular bone, rather than cortical bone, was most strongly associated with fracture risk (although it should be recognized that distinguishing cortical from trabecular bone with HRpQCT is imperfect 6 ). Osteoporotic fractures tend resolution (voxel size 500-1000 μm). QCT can be applied to the peripheral skeleton where the effective radiation dose is much lower and higher resolution images can be obtained -a technique known as high-resolution peripheral QCT (HRpQCT). The voxel size of HRpQCT is 82 μm (close to the diameter of trabeculae and larger cortical pores); thus, in addition to BMD, the HRpQCT images can be used to quantify geometric and microstructural properties including trabecular bone volume, number, thickness (indirectly), spacing and heterogeneity, as well as cortical thickness and porosity. The images can also be used to generate virtual models for micro-finite element analysis to estimate bone stiffness and failure load. Early clinical studies using HRpQCT described the expected age-related decrease in BMD and offered some new insights into microarchitectural ageing. For example, trabecular number decreases in women with ageing, but in men trabecular thickness decreases and trabecular number is relatively preserved 2 . It was also shown that micro architectural properties differed between women with and without fragility fractures, which was partially independent of DXA-based BMD 
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High-resolution peripheral quantitative CT (HRpQCT) provides more detailed information than older methods. A new study shows that radial and tibial HRpQCT measurements are associated with incident fracture in postmenopausal women. However, it is unclear whether HRpQCT improves fracture risk prediction enough to justify its use in clinical practice.
to occur at the metaphyses of bones (distal radius, proximal humerus and femur) where the proportion of trabecular bone is high. We need to be cautious in the interpretation of microarchitectural features such as trabecular thickness, because these studies used the first-generation HRpQCT technique with a voxel size of 82 μm (in contrast to secondgeneration HRpQCT devices that have a voxel size of 61 μm), which is insufficient to directly measure trabecular thickness. We should also be cautious about the interpretation of strength using micro-finite element models of the radius and tibia, given that most fractures occurred at other sites (only 11 out of 24 fractures affected the forearm and ankle in the study by Burt and colleagues 4 ). The question remains as to whether HRpQCT will become a commonly used test in clinical practice. The challenges here relate to the limited use of the technique. Currently, there is insufficient data to test whether the HRpQCT-based measurements of BMD could be used to calculate 10-year risk of osteoporotic fractures and to guide treatment decisions. The technique was not included in the clinical trials evaluating most of the drugs licensed for osteoporosis, as the method was not available at the time; thus, it is unknown what level of BMD measured by HRpQCT is associated with successful fracture risk reduction with any osteoporosis drug. Larger prospective studies are under way 7 , but until these studies have concluded, the HRpQCT technique will not be used in clinical practice.
One surprising finding from the study 4 was that the rate of bone loss was not associated with fracture risk. There have been at least three cohort studies [8] [9] [10] that have shown that rates of bone loss from the proximal femur or distal radius were predictive of non-vertebral fractures, independently of baseline BMD (or other key risk factors, such as prior fracture). Indeed, one of these reports was from CaMos (the same as for Burt et al. 4 ), but the study used a much larger cohort and included both men and women, evaluated many more fractures and, most importantly, excluded patients who were taking osteoporosis medications. The study by Burt and colleagues 4 included only women, half of whom were taking osteoporosis medications, a factor known to have a large influence on the rate of bone loss. Thus, we should not put too much weight on the finding of no association between fracture and change in HRpQCT measurements; that still remains an open question. 
